Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04776876
Status:
WITHDRAWN
Last Update Posted:
2021-09-29
First Post:
2021-02-08
Brief Title:
Retifanlimab INCMGA00012 and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome
Sponsor:
Organization:
MD Anderson Cancer Center